7 Recruiting Acute Myeloid Leukemia (AML) Phase 2 Clinical Trials
Active phase 2 studies for acute myeloid leukemia (aml) enrolling across the USA. Verify eligibility and contact site coordinators.
All Acute Myeloid Leukemia (AML) studiesPhase 2 Studies for Acute Myeloid Leukemia (AML)
🔵 Active, Not Recruiting Phase2
A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia
📍 City of Hope Nat'l Medical Center — Duarte, California
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase2
Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker
📍 Houston Methodist Neal Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase1 / Phase2
A Phase 1 Open-Label, Dose-Ranging Safety and Pharmacokinetics Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML)
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
📍 UCLA Medical Center — Los Angeles, California
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
📍 Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔ 🟢 Recruiting Phase2
Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔